SUMMARY Cerebrovascular responses were studied in preterm infants by Doppler ultrasound and cerebral electrical impedance for one hour after intravenous indomethacin infusion for patent ductus arteriosus. Indomethacin in a dose of 0-2 mg/kg body weight was infused over five minutes in one group of infants (20 doses) and over 20 minutes in a second group of infants (16 doses). There were no significant differences between the two groups in birth weight (mean=1068 g, range , gestational age (mean 28-4 weeks, range 25-31), or postnatal age (mean 18-1 days, range 6-42).
Indomethacin is widely used to close haemodynamically important patent ductus arteriosus in neonates.1 2 Its pharmacokinetics have been studied3 6and its comparative safety established in a collaborative study with a one year follow up.7 Various dose regimens have been studied to maximise the clinical efficacy.8 9 Concern arose recently after the observation that therapeutic doses of indomethacin given to preterm neonates may cause a reduction in Doppler blood flow velocity in intracranial arteries.10 11 Cowan'0 found a reduction of up to 75% in mean Doppler flow velocity in the intracranial arteries after four doses of 0-2 mg/kg body weight had been given in less than three minutes. Evans et all' found a mean reduction of 39% after 15 doses of 0-2 mg/kg body weight had been given within 15 seconds. Cerebral blood flow measured by the 133xenon clearance technique has been reported to fall by a mean of 22% after six doses of 0-2 mg/kg body weight were given over one minute. 12 Reduction in cerebral blood flow has also been reported in the fetuses and newborns of several animal species."-16 This may be caused by constric- tion of the microvasculature'7-19 in response to 8 inhibition of prostaglandin synthesis within the endothelium.20 Extrapolating from the result that the largest reduction in cerebral blood flow velocity occurred after the fastest infusion, Cowan10 recommended that indomethacin be given slowly over at least five minutes. This study was designed to investigate whether cerebrovascular responses measured by both Doppler ultrasound and cerebral electrical impedance were different when indomethacin was infused over five minutes from when it was infused over 20 minutes.
Patients and methods
The study was performed in two stages. Doppler ultrasound examination of blood flow velocity in the anterior cerebral artery was carried out through the anterior fontanelle with a continuous wave system using fast Fourier analysis of the Doppler frequency shift spectrum (Angioscan III). A 4 MHz probe was used in larger babies and an 8 MHz probe in smaller babies. The maximum signal was sought using sound and visual display of the spectrum from the region of the anterior cerebral artery. The Angioscan automatically calculated a mean frequency shift from the spectral information averaged over a memory block that varied from four to six heart beats, depending on the heart rate. The percentage change from the average of the three baseline measurements of the mean frequency shift was calculated. Doppler examinations were made intermittently, with the probe removed between examinations.
The repeatability of the two methods was calculated to ascertain whether any observed changes might be accounted for by poor repeatability of the techniques. The repeatability coefficient (defined as the limits within which 95% of the differences between two measurements of the same process lay)23 was calculated from baseline measurements made one and three minutes before indomethacin was given, making certain that the clinical state of the baby was stable during this period.
Doppler examinations were carried out and peak amplitude of cerebral impedance noted at one, two, four, six, eight, and 10 minutes, and then at five minute intervals to one hour from the time indomethacin infusion was started.
Results are shown as mean (SE) . Differences between the impedance and Doppler measurements before and after indomethacin were sought by two way analysis of variance, and if a significant difference existed the paired t test was used to establish the significance of differences between individual measurements. A p value of <0*05 was accepted as significant. The influence of gestational and postnatal age on responses was assessed by multiple linear regression analysis.
Results
The responses of Doppler mean flow velocity and cerebral electrical impedance after infusion of indomethacin over five minutes are shown in figs 1 and 2. The maximum reduction in Doppler mean flow velocity (-20(4.2)%) occurred four minutes after starting the infusion, and the maximum reduction of cerebral electrical impedance (-26(3-9)%) occurred by one minute; these values were significantly different from the baseline values (p<O01 in both cases). The responses after indomethacin -.
-.
Discussion
The early reduction in Doppler mean flow velocity after the five minute infusion of indomethacin is similar to previously published results.10 11 Cerebral blood flow decreases within two minutes in newborn animals. [17] [18] [19] This change is dose dependent, and in the newborn dog is about 20% with the dose used in this study,14 24 which may be just enough to affect the cerebral circulation when infused rapidly but may not have an effect after slower infusion where instantaneous brain blood concentrations are lower. No previous studies have addressed the effect of different infusion rates on cerebrovascular responses. Another possible explanation as to why there was a difference in response after infusion at the two rates is that there was a difference in the two study groups. There were, however, no differences between the groups in gestational age, postnatal age, birth weight, carbon dioxide tension at the start of the infusion, and clinical state.
Whether there are any potentially deleterious effects of a reduction in cerebral blood flow associated with treatment with indomethacin is unknown. In experiments in animals, decreases in cerebral blood flow associated with indomethacin have not been associated with a reduction in cerebral metabolic rates of oxygen or glucose.13 25 26 The repeatability coefficients of both Doppler mean flow velocity and cerebral electrical impedance suggest that the reduction after the five minute infusion of indomethacin was not likely to have been accounted for by measurement variability. Results of both techniques suggest reductions in cerebral blood flow27 of about the same magnitude as seen in newborn animals15 and humans.12 Hypercapnia, postnatal age, and gestational age may affect the magnitude of the cerebrovascular response after infusion of indomethacin. Cerebral blood flow is reduced more when there is hypercapnia26 28 29 but no similar effect of carbon dioxide tension was seen in this study on Doppler mean flow velocity or cerebral electrical impedance. In newborn dogs postnatal age is an important determinant of the magnitude of cerebrovascular response, but we saw no such effect. No studies have directly addressed the effect of gestational age on cerebrovascular responses but it seems likely that responses should be greater at lower gestational age down to an unknown lower limit. 15 We did not observe an effect of gestational age.
Indomethacin has effects on blood pressure control mediated by the autonomic nervous and renin angiotensin systems.30 31 Evans et all' found a mean increase of 15% in blood pressure in the neonate after indomethacin had been given. In this study there was no consistent change in blood pressure after infusion at either rate.
The efficacy of indomethacin in closing the patent ductus arteriosus was not examined in this study, but it seems to be associated with steady state serum concentration.3-6 Because the half life of indomethacin in the neonate is at least eight hours and usually about 20 hours3 6 there should be no difference in serum concentrations after infusion at the different rates used in this study, and hence efficacy would be expected to be the same.
We recommend that in clinical practice and in studies to determine optimal dosage schedules indomethacin be infused over 20 minutes or longer. Until further data are available there must be concern about the possible deleterious effects of the apparent reduction in cerebral blood flow observed with shorter infusion periods. 
